Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Trial Group Obtains Defense Verdict for AstraZeneca

March 19, 2010

WASHINGTON, DC, March 19, 2010 — A jury in Middlesex County, New Jersey has ruled in favor of AstraZeneca in the first U.S. trial over its antipsychotic medication Seroquel. The state court panel returned its verdict March 18 following six hours of deliberations. A trial group from Covington & Burling LLP led by Mike Brock worked with teams from Dechert LLP and Kaye Scholer LLP led by Diane Sullivan and Arthur Brown, respectively, in securing the defense verdict in this month-long trial.

The lawsuit was brought by Ted Baker, a Louisiana man who claimed the medication caused his diabetes. In reaching its verdict, the jury found that AstraZeneca had provided prescribing doctors an adequate warning about the risk of diabetes.

Mr. Brock, chair of Covington’s product liability practice and a fellow of the American College of Trial Lawyers, co-tried the case. He was assisted by partner Paul Schmidt, and associates Kim Branscome and Shannon Lang.

Share this article: